| Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00121277) | University Health Network, Toronto | 2005-09-01 |
| Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome (NCT00208026) | Children's Hospital of Philadelphia | 2005-09-01 |
| An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates (NCT00760279) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2005-09-01 |
| Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide (NCT02778594) | Bial - Portela C S.A. | 2005-09-01 |
| Stem Cell Study for Patients With Heart Disease (NCT00221182) | Foundation for Biomedical Research and Innovation | 2005-09-01 |
| Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease (NCT00159172) | Assistance Publique - Hôpitaux de Paris | 2005-09-01 |
| Pharmacokinetics of Salmeterol Via HandiHaler® in Healthy Male Volunteers (NCT02254187) | Boehringer Ingelheim | 2005-09-01 |
| Magnetic Resonance (MR) in Asthmatic Patients (NCT00188487) | University Health Network, Toronto | 2005-09-01 |
| A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients (NCT00329589) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2005-09-01 |
| Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00126620) | University Health Network, Toronto | 2005-09-01 |
| PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers (NCT00291395) | Danish Headache Center | 2005-09-01 |
| Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients (NCT00177840) | University of Pittsburgh | 2005-09-01 |
| Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions (NCT01179659) | Kremers Urban Development Company | 2005-09-01 |
| Alzheimer Patients and the Snoezelen Program (NCT00548951) | Queen's University | 2005-09-01 |
| Effect of Hip Adduction Combination With Knee Extension Exercise on Morphology of Quadriceps Muscles, Pain and Functional Outcomes in Patients With PFPS (NCT00166777) | National Taiwan University Hospital | 2005-09-01 |
| Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers (NCT02256813) | Boehringer Ingelheim | 2005-09-01 |
| Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) (NCT00138632) | Novartis | 2005-09-01 |
| A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions (NCT00865761) | Actavis Inc. | 2005-09-01 |
| An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) (NCT00127101) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START) (NCT00243880) | Columbia University | 2005-09-01 |
| Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis (NCT00230204) | Sheba Medical Center | 2005-09-01 |
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer (NCT00329368) | Endocyte | 2005-09-01 |
| A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. (NCT00677001) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2005-09-01 |
| Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment (NCT00288925) | Zeria Pharmaceutical | 2005-09-01 |
| The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers (NCT02183623) | Boehringer Ingelheim | 2005-09-01 |
| Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects (NCT00320307) | GlaxoSmithKline | 2005-09-01 |
| Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients (NCT00229749) | Sarepta Therapeutics, Inc. | 2005-09-01 |
| Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer (NCT00100750) | National Cancer Institute (NCI) | 2005-09-01 |
| Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00255658) | National Cancer Institute (NCI) | 2005-09-01 |
| Hypnosis for Eye Surgery (NCT00176098) | Heidelberg University | 2005-09-01 |
| Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia (NCT00314639) | Laval University | 2005-09-01 |
| Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers (NCT02183506) | Boehringer Ingelheim | 2005-09-01 |
| Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg (NCT00647816) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa (NCT02774564) | Bial - Portela C S.A. | 2005-09-01 |
| Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy (NCT00243789) | Cooperative International Neuromuscular Research Group | 2005-09-01 |
| Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food (NCT02852876) | Astellas Pharma Europe Ltd. | 2005-09-01 |
| Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients (NCT00268918) | Dana-Farber Cancer Institute | 2005-09-01 |
| Anastrozole 1 mg Tablets Under Fed Conditions (NCT01183390) | Teva Pharmaceuticals USA | 2005-09-01 |
| The Effect of Aerobic Exercise on Learning After Stroke (NCT00228306) | University of Kansas | 2005-09-01 |
| The Effects of L-arabinose on Intestinal Sucrase Activity in Man (NCT00302302) | University of Copenhagen | 2005-09-01 |
| Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer (NCT00174434) | Pfizer | 2005-09-01 |
| Evaluating Tools for Health Promotion and Disease Prevention (NCT00164658) | Centers for Disease Control and Prevention | 2005-09-01 |
| Bioavailability Study of Propranolol Under Fed Conditions (NCT00652600) | Par Pharmaceutical, Inc. | 2005-09-01 |
| NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS) (NCT00248404) | Kiadis Pharma | 2005-09-01 |
| Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer (NCT00207090) | R-Pharm | 2005-09-01 |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT01172028) | University of Arizona | 2005-09-01 |
| Free Fatty Acids and Vascular Function in Subjects With Diabetes (NCT00153179) | Brigham and Women's Hospital | 2005-09-01 |
| Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma (NCT00707278) | University of Utah | 2005-09-01 |
| Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy (NCT00179608) | Celgene | 2005-09-01 |
| A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy (NCT00225095) | Mesoblast International Sàrl | 2005-09-01 |
| Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants (NCT00606437) | Duke University | 2005-09-01 |
| A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer (NCT00401765) | Centocor, Inc. | 2005-09-01 |
| Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg (NCT00649987) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response (NCT00121160) | Fred Hutchinson Cancer Center | 2005-09-01 |
| NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel (NCT00229593) | University of Washington | 2005-09-01 |
| Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer (NCT00179699) | Celgene Corporation | 2005-09-01 |
| Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00244985) | Roswell Park Cancer Institute | 2005-09-01 |
| Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures (NCT00161629) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-09-01 |
| Vaccine Therapy in Treating Patients With Head and Neck Cancer (NCT00404339) | Robert Ferris | 2005-09-01 |
| Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients. (NCT00227461) | Kessler Foundation | 2005-09-01 |
| Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) (NCT00111813) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Insulin and Sarcopenia in the Elderly (NCT00690534) | The University of Texas Medical Branch, Galveston | 2005-09-01 |
| V930 First in Man (FIM) Study (V930-002)(COMPLETED) (NCT00250419) | Merck Sharp & Dohme LLC | 2005-09-01 |
| PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma (NCT00253474) | National Institutes of Health Clinical Center (CC) | 2005-09-01 |
| Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma (NCT00412581) | M.D. Anderson Cancer Center | 2005-09-01 |
| Atkins Diet for Difficult-to-Control Headaches in Teenagers (NCT00181064) | Johns Hopkins University | 2005-09-01 |
| Study of the Effects of Pomegranate Tablets on Enlarged Prostates (NCT00381108) | University of California, Irvine | 2005-09-01 |
| ATS-1 Needle Free Injection Device Study-a Device for Administering r-hGH (Saizen) to Treat Growth Hormone Deficiency (NCT00407472) | EMD Serono | 2005-09-01 |
| Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 (NCT00629837) | Bayer | 2005-09-01 |
| Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents (NCT00522769) | Kaiser Permanente | 2005-09-01 |
| Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00478075) | Mayo Clinic | 2005-09-01 |
| 12-step Facilitation for the Dually Diagnosed (NCT00583440) | University of New Mexico | 2005-09-01 |
| Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse (NCT00602732) | Butler Hospital | 2005-09-01 |
| Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg (NCT00647608) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP) (NCT00167453) | University of Saskatchewan | 2005-09-01 |
| The Effect of Blood Transfusion on Blood Flow to the Intestines of Premature Infants (NCT00167388) | University of Pittsburgh | 2005-09-01 |
| Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement (NCT00175461) | University of British Columbia | 2005-09-01 |
| A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting Conditions (NCT00864981) | Sandoz | 2005-09-01 |
| Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer (NCT02182102) | Boehringer Ingelheim | 2005-09-01 |
| IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC) (NCT00351949) | Immutep S.A.S. | 2005-09-01 |
| Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia (NCT00301093) | Dana-Farber Cancer Institute | 2005-09-01 |
| A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist (NCT00231907) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Effect of Candesartan in Alcoholic Liver Fibrosis (NCT00990639) | Yonsei University | 2005-09-01 |
| A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1 (NCT00239187) | OPKO Health, Inc. | 2005-09-01 |
| Intervention for Support Persons to Help Smokers Quit (NCT00379054) | Mayo Clinic | 2005-09-01 |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors (NCT00413322) | Valerio Therapeutics | 2005-09-01 |
| Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. (NCT00162136) | R-Pharm | 2005-09-01 |
| Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg (NCT00649779) | Mylan Pharmaceuticals Inc | 2005-09-01 |
| Study of Glaucoma Treatment With Food Additives (NCT00196677) | Future Products Management | 2005-09-01 |
| The Energy Balance Study (NCT01029483) | Oregon Health and Science University | 2005-09-01 |
| Granisetron 1 mg Tablets Under Fasting Conditions (NCT00834717) | Teva Pharmaceuticals USA | 2005-09-01 |
| Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics (NCT00136292) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2005-08-24 |
| NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting) (NCT00142454) | Ludwig Institute for Cancer Research | 2005-08-24 |
| GSK159802 In Healthy Male Subjects And Asthmatics (NCT00364273) | GlaxoSmithKline | 2005-08-24 |
| A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function (NCT00139620) | OSI Pharmaceuticals | 2005-08-22 |
| Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC) (NCT00184015) | University of Southern California | 2005-08-18 |
| Cyclophosphamide Drug Interaction Study In Cancer Patients (NCT00334646) | GlaxoSmithKline | 2005-08-10 |
| Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma (NCT00327197) | GlaxoSmithKline | 2005-08-02 |
| Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers (NCT00377923) | IBSA Institut Biochimique SA | 2005-08-01 |
| Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee (NCT00372801) | GlaxoSmithKline | 2005-08-01 |